Poland· PL-100215795
Hepatect CP
A hepatitis b immunoglobulin product containing immunoglobulinum humanum hepatitidis b ad usum intravenosum, registered in Poland by Biotest Pharma GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Immunoglobulinum humanum hepatitidis B ad usum intravenosum
- Manufacturer
- Biotest Pharma GmbH
- Country
- Poland (PL)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909990921775
- gtin05909990729456
- gtin05909990729463
- gtin05909990729470
- gtin04036124017286
- gtin04036124017279
- gtin04036124016395
- gtin04036124020095
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hepatitis b immunoglobulin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHepatect CP 100units/2ml solution for infusion vialsBiotest (UK) Ltd
- SwitzerlandHepatect CP, InfusionslösungBiotest (Schweiz) AG
- SpainHEPATECT 50 UI/ml SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- Japan乾燥抗ＨＢｓ人免疫グロブリン
- FranceIMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB 100 UI/mL, solution injectable en seringue préremplie (IM)LFB-BIOMEDICAMENTS
- CanadaHEPAGAM BKI BIOPHARMA LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2fa0b6b-2842-45cd-b75d-bd6d737294ca GET /v1/drugs/c2fa0b6b-2842-45cd-b75d-bd6d737294ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "50 j.m./ml",
"packaging": "05909990921775 ¦ Rp ¦ Skasowane ¦ 28708\n1 fiol. 100 ml\n05909990729456 ¦ Rp ¦ Skasowane ¦ 53113\n1 fiol. 2 ml\n05909990729463 ¦ Rp ¦ Skasowane ¦ 53114\n1 fiol. 10 ml\n05909990729470 ¦ Rp ¦ Skasowane ¦ 53115\n1 fiol. 40 ml\n04036124017286 ¦ Rp ¦ 133793\n1 fiol. 10 ml\n04036124017279 ¦ Rp ¦ 133794\n1 fiol. 40 ml\n04036124016395 ¦ Rp ¦ 133795\n1 fiol. 2 ml\n04036124020095 ¦ Rp ¦ 133796\n1 fiol. 100 ml",
"substance": "Immunoglobulinum humanum hepatitidis B 50 j.m./ml",
"common_name": "Immunoglobulinum humanum hepatitidis B ad usum intravenosum",
"pl_product_id": "100215795",
"pozwolenie_nr": "15961",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.